SCHEMBL4532416

SCHEMBL4532416

CCN1CCc2cc(/C(N)=C/S)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.45
NOTUM Q6P988 1/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC3 O15379 1/20 0.39
CYP2C19 P33261 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
S1PR1 P21453 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.37
TP53 P04637 5/20 0.37
POLB P06746 2/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10230451 0.81 ACHE (0.45) ACHENOTUMHDAC1HDAC8HDAC6
SCHEMBL20178650 0.80 ACHE (0.54) ACHENOTUMTP53POLBKDM4E
SCHEMBL15075870 0.78 NOTUM (0.58) NOTUMTP53KDM4EALDH1A1HPGD
SCHEMBL20178648 0.75 SRD5A1 (0.58) ACHETP53POLBKDM4EALDH1A1
SCHEMBL27611315 0.74 ACHE (0.57) ACHENOTUMS1PR1KDM4EALDH1A1
SCHEMBL30197112 0.73 ALDH1A1 (0.53) ACHEHDAC1HDAC8HDAC6HDAC3
SCHEMBL1310717 0.72 HDAC1 (0.49) ACHEHDAC1HDAC8HDAC6HDAC3
SCHEMBL20178649 0.72 ALDH1A1 (0.52) ACHEHDAC1HDAC8HDAC6HDAC3
SCHEMBL13534809 0.72 NOTUM (0.47) ACHENOTUMS1PR1TP53KDM4E
SCHEMBL30168583 0.72 ATAD2 (0.55) ACHENOTUMS1PR1TP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194202-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELI LILLY AND COMPANY 2019-06-27 US disclosed
US-9951073-B2 Compounds and compositions for treating chemical warfare agent-induced injuries HYDRA BIOSCIENCES, INC. (US) 2018-04-24 US disclosed
US-20130303521-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC (US) 2013-11-14 US disclosed
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC. 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 ACHE 11/4885NOTUM 813/4885HDAC1 1398/4885
US-20130303521-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 ACHE 11/4885NOTUM 813/4885HDAC1 1398/4885
US-20190194202-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 ACHE 11/4885NOTUM 813/4885HDAC1 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.